CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomasJoseph Flores‐Toro, Jeffrey K. Harrison, Meenal Datta et al.|Proceedings of the National Academy of Sciences|2019Cited by 330
Contemporary RNA Therapeutics for GlioblastomaKaitlyn Melnick, Elias Sayour, Farhad Dastmalchi et al.|NeuroMolecular Medicine|2021Cited by 45
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumorsAlayna E. Ernster, Ashley Ghiaseddin, Anjelica Body et al.|Journal of Neuro-Oncology|2023Cited by 9
Developing a computable phenotype for glioblastomaSandra C. Yan, Ashley Ghiaseddin, Kaitlyn Melnick et al.|Neuro-Oncology|2023Cited by 2